107 related articles for article (PubMed ID: 2777134)
1. Serum lactic dehydrogenase and primary carcinoma of the ovary.
Younis JS; Zeevi D; Hadani PE; Anteby SO
Gynecol Obstet Invest; 1989; 28(1):47-50. PubMed ID: 2777134
[TBL] [Abstract][Full Text] [Related]
2. Total lactate dehydrogenase and its isozymes in serum from patients with primary carcinoma of the ovary.
Kikuchi Y; Hisano A; Kuki E; Hirata J; Nagata I
Gynecol Obstet Invest; 1991; 31(3):161-5. PubMed ID: 2071055
[TBL] [Abstract][Full Text] [Related]
3. Lactate dehydrogenase is correlated with clinical stage and grade and is downregulated by si‑SAΤB1 in ovarian cancer.
Xiang J; Zhou L; Zhuang Y; Zhang J; Sun Y; Li S; Zhang Z; Zhang G; He Y
Oncol Rep; 2018 Nov; 40(5):2788-2797. PubMed ID: 30132561
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of pretreatment serum LDH in patients with limited disease small-cell lung carcinoma.
Stokkel MP; Van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
Int J Biol Markers; 1997; 12(4):162-7. PubMed ID: 9582606
[TBL] [Abstract][Full Text] [Related]
5. Serum lactic dehydrogenase and its isoenzymes in patients with ovarian dysgerminoma.
Yoshimura T; Takemori K; Okazaki T; Suzuki A
Int J Gynaecol Obstet; 1988 Dec; 27(3):459-65. PubMed ID: 2904916
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of serum and peritoneal fluid lactate dehydrogenase in epithelial ovarian cancer.
Yüce K; Baykal C; Genç C; Al A; Ayhan A
Eur J Gynaecol Oncol; 2001; 22(3):228-32. PubMed ID: 11501779
[TBL] [Abstract][Full Text] [Related]
7. Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L.
Liu R; Cao J; Gao X; Zhang J; Wang L; Wang B; Guo L; Hu X; Wang Z
Tumour Biol; 2016 Oct; 37(10):14083-14088. PubMed ID: 27511116
[TBL] [Abstract][Full Text] [Related]
8. Significance of serum and peritoneal fluid lactate dehydrogenase levels in ovarian cancer.
Boran N; Kayikçioğlu F; Yalvaç S; Tulunay G; Ekinci U; Köse MF
Gynecol Obstet Invest; 2000; 49(4):272-4. PubMed ID: 10828712
[TBL] [Abstract][Full Text] [Related]
9. Serum lactic dehydrogenase: a tumor marker for dysgerminoma.
Schwartz PE; Morris JM
Obstet Gynecol; 1988 Sep; 72(3 Pt 2):511-5. PubMed ID: 3405571
[TBL] [Abstract][Full Text] [Related]
10. Serum lactate dehydrogenase level in patients with nasopharyngeal carcinoma.
Liaw CC; Wang CH; Huang JS; Kiu MC; Chen JS; Chang HK
Acta Oncol; 1997; 36(2):159-64. PubMed ID: 9140432
[TBL] [Abstract][Full Text] [Related]
11. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
[TBL] [Abstract][Full Text] [Related]
12. Quantitative biochemical analysis of lactate dehydrogenase in human ovarian tissues: correlation with tumor grade.
Simaga S; Osmak M; Babic D; Sprem M; Vukelic B; Abramic M
Int J Gynecol Cancer; 2005; 15(3):438-44. PubMed ID: 15882167
[TBL] [Abstract][Full Text] [Related]
13. Ovarian germinoma (dysgerminoma) with elevated serum lactic dehydrogenase: case report and review of literature.
Sheiko MC; Hart WR
Cancer; 1982 Mar; 49(5):994-8. PubMed ID: 7059933
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma.
Egberts F; Kotthoff EM; Gerdes S; Egberts JH; Weichenthal M; Hauschild A
Eur J Cancer; 2012 Mar; 48(5):695-702. PubMed ID: 21917447
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal fluid lactate dehydrogenase in ovarian cancer.
Schneider D; Halperin R; Langer R; Bukovsky I; Herman A
Gynecol Oncol; 1997 Sep; 66(3):399-404. PubMed ID: 9299252
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors--correlation between tumor markers and histological types of ovarian tumors].
Konishi I; Fujii S; Okamura H; Sakahara H; Endo K; Torizuka K; Suzuki A; Mori T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):827-36. PubMed ID: 2426374
[TBL] [Abstract][Full Text] [Related]
17. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.
Lee DS; Park KR; Kim SJ; Chung MJ; Lee YH; Chang JH; Kang JH; Hong SH; Kim MS; Kim YS
Tumour Biol; 2016 Jan; 37(1):619-25. PubMed ID: 26240025
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of serum lactic dehydrogenase in non-Hodgkin's lymphoma.
Hagberg H; Siegbahn A
Scand J Haematol; 1983 Jul; 31(1):49-56. PubMed ID: 6867608
[TBL] [Abstract][Full Text] [Related]
19. Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma.
Diamandis EP; Scorilas A; Fracchioli S; Van Gramberen M; De Bruijn H; Henrik A; Soosaipillai A; Grass L; Yousef GM; Stenman UH; Massobrio M; Van Der Zee AG; Vergote I; Katsaros D
J Clin Oncol; 2003 Mar; 21(6):1035-43. PubMed ID: 12637468
[TBL] [Abstract][Full Text] [Related]
20. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.
Morales-Vásquez F; Pedernera E; Reynaga-Obregón J; López-Basave HN; Gómora MJ; Carlón E; Cárdenas S; Silva-Ayala R; Almaraz M; Méndez C
J Ovarian Res; 2016 Jul; 9(1):41. PubMed ID: 27388275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
